Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads

Autores
Saviola, Anthony J.; Peichoto, Myriam Carolina; Machessy, Stephen P.
Año de publicación
2014
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Animal venoms represent a diverse source of potentially valuable therapeutic compounds due to the high specificity and the potent biological activity of many toxins. Snake venom toxins, particularly disintegrins and proteases from viper venoms, have yielded therapeutics with anti-cancer and hemostatic dysfunction activities. However, venoms from rear-fanged ??colubrid?? snakes have rarely been analyzed from the perspective of potential lead compound development. Here, we discuss recent progress in the analysis of these venoms, focusing on several studies of specific venom components as well as transcriptomic and proteomic surveys. Currently available ?omic technologies largely circumvent the problematic low venom yields of most rear-fanged snakes, and because their basic biology is often very different from the well-studied front-fanged snakes, there is great potential for novel compound discovery in their venoms.
Animal venoms represent a diverse source of potentially valuable therapeutic compounds due to the high specificity and the potent biological activity of many toxins. Snake venom toxins, particularly disintegrins and proteases from viper venoms, have yielded therapeutics with anti-cancer and hemostatic dysfunction activities. However, venoms from rear-fanged “colubrid” snakes have rarely been analyzed from the perspective of potential lead compound development. Here, we discuss recent progress in the analysis of these venoms, focusing on several studies of specific venom components as well as transcriptomic and proteomic surveys. Currently available –omic technologies largely circumvent the problematic low venom yields of most rear-fanged snakes, and because their basic biology is often very different from the well-studied front-fanged snakes, there is great potential for novel compound discovery in their venoms.
Fil: Saviola, Anthony J.. Univeristy Of Northem Colorado; Estados Unidos
Fil: Peichoto, Myriam Carolina. Ministerio de Salud. Instituto Nacional de Medicina Tropical; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; Argentina
Fil: Machessy, Stephen P.. Univeristy Of Northem Colorado; Estados Unidos
Materia
Colubrid
Venom
Protein
Structure/Function
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/17030

id CONICETDig_1f3de8b4e0031958b37799ef2c84b11b
oai_identifier_str oai:ri.conicet.gov.ar:11336/17030
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leadsSaviola, Anthony J.Peichoto, Myriam CarolinaMachessy, Stephen P.ColubridVenomProteinStructure/Functionhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Animal venoms represent a diverse source of potentially valuable therapeutic compounds due to the high specificity and the potent biological activity of many toxins. Snake venom toxins, particularly disintegrins and proteases from viper venoms, have yielded therapeutics with anti-cancer and hemostatic dysfunction activities. However, venoms from rear-fanged ??colubrid?? snakes have rarely been analyzed from the perspective of potential lead compound development. Here, we discuss recent progress in the analysis of these venoms, focusing on several studies of specific venom components as well as transcriptomic and proteomic surveys. Currently available ?omic technologies largely circumvent the problematic low venom yields of most rear-fanged snakes, and because their basic biology is often very different from the well-studied front-fanged snakes, there is great potential for novel compound discovery in their venoms.Animal venoms represent a diverse source of potentially valuable therapeutic compounds due to the high specificity and the potent biological activity of many toxins. Snake venom toxins, particularly disintegrins and proteases from viper venoms, have yielded therapeutics with anti-cancer and hemostatic dysfunction activities. However, venoms from rear-fanged “colubrid” snakes have rarely been analyzed from the perspective of potential lead compound development. Here, we discuss recent progress in the analysis of these venoms, focusing on several studies of specific venom components as well as transcriptomic and proteomic surveys. Currently available –omic technologies largely circumvent the problematic low venom yields of most rear-fanged snakes, and because their basic biology is often very different from the well-studied front-fanged snakes, there is great potential for novel compound discovery in their venoms.Fil: Saviola, Anthony J.. Univeristy Of Northem Colorado; Estados UnidosFil: Peichoto, Myriam Carolina. Ministerio de Salud. Instituto Nacional de Medicina Tropical; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; ArgentinaFil: Machessy, Stephen P.. Univeristy Of Northem Colorado; Estados UnidosTaylor2014-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/17030Saviola, Anthony J.; Peichoto, Myriam Carolina; Machessy, Stephen P.; Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads; Taylor; Toxin Reviews; 33; 4; 7-2014; 185-2011556-95431556-9551enginfo:eu-repo/semantics/altIdentifier/url/http://www.tandfonline.com/doi/full/10.3109/15569543.2014.942040info:eu-repo/semantics/altIdentifier/doi/10.3109/15569543.2014.942040info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:11:51Zoai:ri.conicet.gov.ar:11336/17030instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:11:51.646CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads
title Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads
spellingShingle Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads
Saviola, Anthony J.
Colubrid
Venom
Protein
Structure/Function
title_short Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads
title_full Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads
title_fullStr Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads
title_full_unstemmed Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads
title_sort Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads
dc.creator.none.fl_str_mv Saviola, Anthony J.
Peichoto, Myriam Carolina
Machessy, Stephen P.
author Saviola, Anthony J.
author_facet Saviola, Anthony J.
Peichoto, Myriam Carolina
Machessy, Stephen P.
author_role author
author2 Peichoto, Myriam Carolina
Machessy, Stephen P.
author2_role author
author
dc.subject.none.fl_str_mv Colubrid
Venom
Protein
Structure/Function
topic Colubrid
Venom
Protein
Structure/Function
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Animal venoms represent a diverse source of potentially valuable therapeutic compounds due to the high specificity and the potent biological activity of many toxins. Snake venom toxins, particularly disintegrins and proteases from viper venoms, have yielded therapeutics with anti-cancer and hemostatic dysfunction activities. However, venoms from rear-fanged ??colubrid?? snakes have rarely been analyzed from the perspective of potential lead compound development. Here, we discuss recent progress in the analysis of these venoms, focusing on several studies of specific venom components as well as transcriptomic and proteomic surveys. Currently available ?omic technologies largely circumvent the problematic low venom yields of most rear-fanged snakes, and because their basic biology is often very different from the well-studied front-fanged snakes, there is great potential for novel compound discovery in their venoms.
Animal venoms represent a diverse source of potentially valuable therapeutic compounds due to the high specificity and the potent biological activity of many toxins. Snake venom toxins, particularly disintegrins and proteases from viper venoms, have yielded therapeutics with anti-cancer and hemostatic dysfunction activities. However, venoms from rear-fanged “colubrid” snakes have rarely been analyzed from the perspective of potential lead compound development. Here, we discuss recent progress in the analysis of these venoms, focusing on several studies of specific venom components as well as transcriptomic and proteomic surveys. Currently available –omic technologies largely circumvent the problematic low venom yields of most rear-fanged snakes, and because their basic biology is often very different from the well-studied front-fanged snakes, there is great potential for novel compound discovery in their venoms.
Fil: Saviola, Anthony J.. Univeristy Of Northem Colorado; Estados Unidos
Fil: Peichoto, Myriam Carolina. Ministerio de Salud. Instituto Nacional de Medicina Tropical; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; Argentina
Fil: Machessy, Stephen P.. Univeristy Of Northem Colorado; Estados Unidos
description Animal venoms represent a diverse source of potentially valuable therapeutic compounds due to the high specificity and the potent biological activity of many toxins. Snake venom toxins, particularly disintegrins and proteases from viper venoms, have yielded therapeutics with anti-cancer and hemostatic dysfunction activities. However, venoms from rear-fanged ??colubrid?? snakes have rarely been analyzed from the perspective of potential lead compound development. Here, we discuss recent progress in the analysis of these venoms, focusing on several studies of specific venom components as well as transcriptomic and proteomic surveys. Currently available ?omic technologies largely circumvent the problematic low venom yields of most rear-fanged snakes, and because their basic biology is often very different from the well-studied front-fanged snakes, there is great potential for novel compound discovery in their venoms.
publishDate 2014
dc.date.none.fl_str_mv 2014-07
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/17030
Saviola, Anthony J.; Peichoto, Myriam Carolina; Machessy, Stephen P.; Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads; Taylor; Toxin Reviews; 33; 4; 7-2014; 185-201
1556-9543
1556-9551
url http://hdl.handle.net/11336/17030
identifier_str_mv Saviola, Anthony J.; Peichoto, Myriam Carolina; Machessy, Stephen P.; Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads; Taylor; Toxin Reviews; 33; 4; 7-2014; 185-201
1556-9543
1556-9551
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://www.tandfonline.com/doi/full/10.3109/15569543.2014.942040
info:eu-repo/semantics/altIdentifier/doi/10.3109/15569543.2014.942040
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Taylor
publisher.none.fl_str_mv Taylor
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842270173365534720
score 13.13397